Influence of recombinant human erythropoietin (rHuEPO) on plasma levels of selected hormones in females with rheumatoid arthritis;Wpływ leczenia niedokrwistości za pomoca̧ ludzkiej erytropoetyny uzyskanej metoda̧ rekombinacji genetycznej (rHuEPO) na stȩżenie w osoczu wybranych hormonów u kobiet chorych na reumatoidalne zapalenie stawów

Polskie Archiwum Medycyny Wewnetrznej

Volumn 114, Issue 2, 2005, Pages 731-737

  Dyjas, Robert ^a   Bułanowski, Maciej ^a   Ficek, Rafał ^a   Witkowicz, Joanna ^a   Chudek, Jerzy ^a   Wiȩcek, Andrzej ^a  

^a Katedra i Klinika Nefrologii   (Poland)

Author keywords

Anaemia; Rheumatoid arthritis; rHuEPO therapy; Serum hormones concentrations

Indexed keywords

ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; CALCIFEDIOL; GROWTH HORMONE; INSULIN; PARATHYROID HORMONE; RECOMBINANT ERYTHROPOIETIN; RENIN;

ANEMIA; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOCRINE FUNCTION; ERYTHROPOIESIS; FEMALE; HORMONE BLOOD LEVEL; HUMAN; KIDNEY FUNCTION; PLASMA RENIN ACTIVITY; RHEUMATOID ARTHRITIS;

EID: 33644745153     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Grossi A.: Management of cancer anemia. J. Chemother., 2004, 4, 112.
2. Lissoni P., Perego M., Veronese E. i wsp.: Endocrine effects of erythropoietin in cancer patients. Hematology, 2004, 9, 363.
3. Keswani S.C., Leitz G.J., Hoke A.: Erythropoietin is neuroprotective in models of HIV sensory neuropaty. Neurosci. Lett., 2004, 371(2-3), 102.
4. Ohls R.K., Ehrenkranz R.A., Wright L.L. i wsp.: Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial. Pediatrics, 2001, 108, 934.
5. Voulgari P. V., Papazisi D., Bai M., Zagorianakou P., Assimakopoulos D., Drosos A.A.: Laryngeal involvement in rheumatoid arthritis. Rheumatol. Int., 2005, [w druku].
6. Pathan E., Joshi V.R.: Rheumatoid arthritis and the kidney. J. Assoc. Physicians India, 2004, 52, 488.
7. Birgegard G., Gudbjorensson B., Haellgren R., Wide L.: Anaemia of chronic inflammatory arthritides: treatment with recombinant human erythropoietin. [w:] Erythropoietin in renal and non-renal anaemias. (red.): Gurland H.J., Moran J., Samtleben W., Scigalla P., Wieczorek L.S., Karger AG., Basel, 1991, 295.
8. Erslev A.J.: Recombinant human erythropoietin (r-HuEPO) therapy in nonrenal anaemia. Erythropoiesis, 1994, 5, 69.
9. Krantz S.: Rheumatoid arthritis-associated anemia, [w:] Recombinant human erythropoietin. Clinical development and progress. Med. Mark. Interac. Inc., 1989, 21.
10. Krantz S., Sawyer S.T., Sawada K.L., Wolfe F., Bocagno: Erythropoietin: receptors and clinical use in rheumatoid arthritis. Int. J. Cell Cloning, 1990, 8, 181.
11. Takashina N., Kondo H., Kashiwazaki S.: Suppressed serum erythropoietin response to anemia and the efficacy of recombinant erythropoietin in the anemia of rheumatoid arthritis. J. Rheumatol., 1990, 17, 885.
12. Fischl M., Galpin J.E., Levine J. i wsp.: Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N. Engl. J. Med., 1990, 21, 1488
13. Means R.T.: Hepcidin and cytokines in anaemia. Hematology, 2004, 9, 357.
14. Roy C.N., Andrews N.C.: Anemia of inflammation: the hepcidin link. Curr. Opin. Hematol., 2005, 12, 107.
15. Kokot K, Wiȩcek A.: Endocrine changes in chronic dialysis patients. [w:] Maher J.F. (red.) Replacement of renal function by dialysis. Kluwer Academic Publishers, Dordrecht, Boston, Lancaster., 1989, wyd. 3, 953.
16. Kokot F., Wiȩcek A., Schmidt-Gayk H. i wsp.: Function of endocrine organs in hemodialyzed patients of long-term erythropoietin therapy. Art. Organs, 1995, 5, 428.
17. Mackiewicz S., Hrycaj P.: Reumatoidalne zapalenie stawów. [w:] Reumatologia. (red.): Mackiewicz S., Zimmermann-Górska I. PZWL, Warszawa, 1995, 87.
18. Kokot F., Kuska J.: Verhalten der Plasmareninaktivitaet und des Aldosterons nach Kochsaltzbeschraenkung und aufrechter Koerperlage bei essentieler Hypertonie. Z. Inn. Med., 1976, 31, 1015.
19. Kokot F., Stupnicki R.: Metody radioimmunologiczne i radiokompetycyjne stosowane w klinice. PZWL, Warszawa 1985.
20. Kokot F., Wiȩcek A.: Arterial hypertension in uraemic patients treated with erythropoietin. Nephron, 1995, 71, 127.
21. Raine A.E.G., Roger S.D.: Effects of erythropoietin on blood pressure. Am. J. Kidney. Dis., 1991, 18, 76.
22. Cascinu S., Fedeli A., Luzi Pedeli S., Catalane G.: Cisplatin-associated anaemia with subcutaneous erythropoietin. A pilot study. Br. J. Cancer, 1993, 67, 156.
23. Herrmann F., Oster W., Mertelsmann R.: Treatment of patients with anaemia of malignancy with recombinant human erythropoietin. [w:] Erythropoietin in renal and non-renal anaemias, (red.): Gurland H.J., Moran J., Samtleben, W., Scigalla P., Wieczorek L.S., Karger AG Basel, 1991, 238.
24. Platanias L., Ratain M.: Use of r-HuEPO in the treatment of the anaemia of cancer. Erythropoiesis, 1992, 3, 107.
25. Kokot F., Wiécek A., Grzeszczak W., Klin M.: Influence of erythropoietin treatment on plasma renin activity, aldosterone, vasopressin and atrial natriuretic peptide in haemodialyzed patients. Mineral Electrolyte Metab., 1990, 16, 25.
26. Heidenrich S., Rahn K.H., Zidek W.: Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels. Kidney Int., 1991, 39, 259.
27. Winerals C.G.: Erythropoietin. Nephrol. Dial. Transplant., 1989, 4, 323.
28. Marti H., Gassmann M., Wenger R.H. i wsp.: Detection of erythropoietin in human liquor: Intrinsic erythropoietin production in the brain. Kidney Int., 1997, 51, 416.
29. Kokot F., Wiȩcek A., Grzeszczak W., Klin M., Żukowska- Szczechowska E.: Influence of erythropoietin treatment on glucose tolerance, insulin, glucagon, gastrin and pancreatic polypeptide secretion in hemodialyzed patients with endstage renal failure. Contrib. Nephrol., 1990, 87, 42.
30. Kokot F., Wiȩcek A.: Evidence that the anaemia of renal failure participates in overall urémic toxicity. Kidney Int, 1997, 52, 83.
31. Nieszporek T., Kokot F., Wiȩcek A., Marcinkowski W., Rudka R., Trembecki J.: Wpływ dlłigotrwałego leczenia ludzka̧ rekombinowana̧ erytropoetyna̧ na wydzielanie hormonów reguluja̧cych przemianȩ wȩglowodanowa̧ u hemodializowanych chorych z przewlekła̧ mocznica̧. Pol. Arch. Med. Wewn., 1995, 94, 488.
32. Templ E., Koeller M., Riedl M., Wagner O., Graninger W., Luger A.: Anterior pituitary function in patients with newly diagnosed rheumatoid arthritis. Br. J. Rheumatol., 1996, 35, 350.
33. Jorgensen C., Maziad H., Bologna C., Sany J.: Kinetics of prolactin release in rheumatoid arthritis. Clin. Exp. Rheumatol, 1995, 13, 705.